Related Subjects:
|Pulmonary Stenosis
|Pulmonary Regurgitation
|Pulmonary Hypertension
|Pulmonary Embolism
Pulmonary Arteriovenous Malformations (PAVMs)
๐ซ Introduction
Pulmonary arteriovenous malformations (PAVMs) are abnormal direct connections between pulmonary arteries and veins, bypassing the normal capillary bed.
This creates a right-to-left shunt โ deoxygenated blood enters systemic circulation without gas exchange.
Consequences include hypoxemia, risk of paradoxical embolism (stroke, brain abscess), and haemoptysis. ๐จ
๐ Epidemiology
- Prevalence โ 2โ3 per 100,000 people (rare).
- ๐งฌ 50โ70% occur in Hereditary Hemorrhagic Telangiectasia (HHT).
- Slightly more common in women.
โ๏ธ Etiology & Pathophysiology
- ๐งฌ HHT (Osler-Weber-Rendu): Autosomal dominant; mutations in ENG, ACVRL1.
Telangiectasias & AVMs in multiple organs (lungs, liver, brain).
- โ Idiopathic: No clear cause, minority of cases.
- ๐ Acquired:
- Hepatic cirrhosis (โ pulmonary flow + angiogenic factors).
- Trauma / surgery (rare).
- Chronic infections (e.g., schistosomiasis).
๐ฉบ Clinical Features
- ๐ฎโ๐จ Dyspnoea, hypoxemia ยฑ cyanosis.
- ๐ Digital clubbing (chronic hypoxemia).
- ๐คง Epistaxis (esp. with HHT).
- ๐ง Neuro complications:
- Stroke (paradoxical embolus).
- Brain abscess (bacteria bypass filtration).
- Risk โ 1โ2%/yr if untreated.
- ๐ซ Haemoptysis, haemothorax (rupture).
- โค๏ธ High-output heart failure (large/multiple PAVMs).
- ๐ง Pulmonary bruit sometimes audible.
๐ Diagnosis
- ๐ท CXR: Well-defined lower lobe nodule/mass (can be normal).
- ๐ Contrast echocardiography (bubble study): Bubbles in LA after a few cycles = intrapulmonary shunt.
- ๐ซ TEE: Rules out intracardiac shunts.
- ๐ฅ CT Pulmonary Angiography (CTPA): Gold standard โ defines size, feeding artery, number.
- ๐งฒ MRI: Occasionally used for additional details.
- ๐ฉธ ABG: Hypoxemia + โ Aโa gradient.
- ๐งฌ Genetic testing: For suspected HHT.
๐งพ Differential Diagnosis
- Intracardiac shunts (ASD, PFO).
- Pulmonary embolism.
- Bronchiectasis.
- Lung cancer.
- Pulmonary sequestration.
- Other cyanotic/hypoxemic disorders.
โ๏ธ Management
- ๐ฏ Goal: Prevent stroke, brain abscess, haemorrhage.
- ๐ฉป Transcatheter embolization (first-line): Coils or plugs to occlude feeding arteries; safe & effective.
- ๐ฉบ Surgical resection: For non-embolizable lesions or complications (lobectomy/segmentectomy).
- ๐งฌ HHT management: Screening of relatives, AVM search in brain/liver, manage epistaxis/bleeds.
- ๐ Preventive measures:
- Air filters on IV lines to avoid air emboli.
- Antibiotic prophylaxis for procedures (controversial, but often used in high-risk cases).
- ๐ Follow-up: Lifelong imaging; repeat embolization may be needed due to recanalization or new AVMs.
๐ Prognosis
With treatment (embolization), outcomes are generally excellent โ
.
Oxygenation improves, risk of neuro complications falls.
Untreated โ risk of paradoxical embolism and haemorrhage remains high.
Patients with HHT require lifelong monitoring.
๐ References
- Shovlin CL et al. British Thoracic Society Clinical Statement on Pulmonary AVMs. Thorax. 2017.
- Faughnan ME et al. International Guidelines for Diagnosis & Management of HHT. J Med Genet. 2011.
- Guttmacher AE et al. Hereditary Hemorrhagic Telangiectasia. N Engl J Med. 1995.
- Meier NM et al. Diagnosis & Management of PAVMs. Curr Treat Options Cardiovasc Med. 2018.